These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18615336)

  • 1. Quantitative renal cortical perfusion in human subjects with magnetic resonance imaging using iron-oxide nanoparticles: influence of T1 shortening.
    Morell A; Ahlstrom H; Schoenberg SO; Abildgaard A; Bock M; Bjørnerud A
    Acta Radiol; 2008 Oct; 49(8):955-62. PubMed ID: 18615336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of renal perfusion abnormalities using an intravascular contrast agent (part 2): results in animals and humans with renal artery stenosis.
    Schoenberg SO; Aumann S; Just A; Bock M; Knopp MV; Johansson LO; Ahlstrom H
    Magn Reson Med; 2003 Feb; 49(2):288-98. PubMed ID: 12541249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new ultrasmall superparamagnetic iron oxide contrast agent Clariscan, (NC100150) for MRI of renal perfusion: experimental study in an animal model.
    Bachmann R; Conrad R; Kreft B; Luzar O; Block W; Flacke S; Pauleit D; Träber F; Gieseke J; Saebo K; Schild H
    J Magn Reson Imaging; 2002 Aug; 16(2):190-5. PubMed ID: 12203767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state--dependence on blood volume and water exchange.
    Bjørnerud A; Johansson LO; Briley-Saebø K; Ahlström HK
    Magn Reson Med; 2002 Mar; 47(3):461-71. PubMed ID: 11870832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-clinical results with Clariscan (NC100150 Injection); experience from different disease models.
    Bjørnerud A; Johansson LO; Ahlström HK
    MAGMA; 2001 May; 12(2-3):99-103. PubMed ID: 11390264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of renal perfusion using an intravascular contrast agent (part 1): results in a canine model.
    Aumann S; Schoenberg SO; Just A; Briley-Saebo K; Bjørnerud A; Bock M; Brix G
    Magn Reson Med; 2003 Feb; 49(2):276-87. PubMed ID: 12541248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection.
    Panting JR; Taylor AM; Gatehouse PD; Keegan J; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
    J Magn Reson Imaging; 1999 Sep; 10(3):404-10. PubMed ID: 10508302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal T(*)(2) perfusion using an iron oxide nanoparticle contrast agent--influence of T(1) relaxation on the first-pass response.
    Bjørnerud A; Johansson LO; Ahlström HK
    Magn Reson Med; 2002 Feb; 47(2):298-304. PubMed ID: 11810673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent.
    Briley-Saebø K; Hustvedt SO; Haldorsen A; Bjørnerud A
    J Magn Reson Imaging; 2004 Oct; 20(4):622-31. PubMed ID: 15390223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.
    Bjerner T; Johansson L; Ericsson A; Wikström G; Hemmingsson A; Ahlström H
    Radiology; 2001 Dec; 221(3):822-6. PubMed ID: 11719685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal hemodynamics and oxygenation in transient renal artery occluded rats evaluated with iron-oxide particles and oxygenation-sensitive imaging.
    Pedersen M; Laustsen C; Perot V; Basseau F; Moonen C; Grenier N
    Z Med Phys; 2010; 20(2):134-42. PubMed ID: 20540904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.
    Briley-Saebo K; Bjørnerud A; Grant D; Ahlstrom H; Berg T; Kindberg GM
    Cell Tissue Res; 2004 Jun; 316(3):315-23. PubMed ID: 15103550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the intravascular contrast agent NC100150 injection in spin-echo and gradient-echo imaging of the heart.
    Taylor AM; Panting JR; Keegan J; Gatehouse PD; Jhooti P; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
    J Cardiovasc Magn Reson; 1999; 1(1):23-32. PubMed ID: 11550338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of uptake and distribution of iron oxide particles (NC100150) in human melanoma xenografts by contrast-enhanced MRI.
    Graff BA; Vangberg L; Rofstad EK
    Magn Reson Med; 2004 Apr; 51(4):727-35. PubMed ID: 15065245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning.
    Simon GH; Bauer J; Saborovski O; Fu Y; Corot C; Wendland MF; Daldrup-Link HE
    Eur Radiol; 2006 Mar; 16(3):738-45. PubMed ID: 16308692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
    Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
    Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent, NC100150 injection: comparison with invasive x-ray angiography in pigs.
    Johansson LO; Nolan MM; Taniuchi M; Fischer SE; Wickline SA; Lorenz CH
    J Cardiovasc Magn Reson; 1999; 1(2):139-43. PubMed ID: 11550346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits.
    Clarke SE; Weinmann HJ; Dai E; Lucas AR; Rutt BK
    Radiology; 2000 Mar; 214(3):787-94. PubMed ID: 10715047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON).
    Korosoglou G; Tang L; Kedziorek D; Cosby K; Gilson WD; Vonken EJ; Schär M; Sosnovik D; Kraitchman DL; Weiss RG; Weissleder R; Stuber M
    J Magn Reson Imaging; 2008 May; 27(5):1175-80. PubMed ID: 18425827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion MR imaging with a superparamagnetic iron oxide using T2-weighted and susceptibility-sensitive echoplanar sequences: evaluation of tumor vascularity in hepatocellular carcinoma.
    Ichikawa T; Arbab AS; Araki T; Touyama K; Haradome H; Hachiya J; Yamaguchi M; Kumagai H; Aoki S
    AJR Am J Roentgenol; 1999 Jul; 173(1):207-13. PubMed ID: 10397128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.